Component
17-beta-Estradiol
17-beta-Estradiol. Species, exposure and limitations are retained in each linked claim.
4 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
The increased PEMT message was accompanied by higher protein expression and enzyme activity in the hepatocyte study.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/choline-research/17456783.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d3585209a8c4db7cfe8b93aa2587fdd570f5e5c42bd3ea8f6195feb60b23b9da", "start_char": 0, "end_char": 1399, "text_sha256": "d3585209a8c4db7cfe8b93aa2587fdd570f5e5c42bd3ea8f6195feb60b23b9da"}
- experimental_model
- Primary-hepatocyte estrogen exposure
- exposure
- 17-beta-estradiol treatment for 24 hours
- limitations
- Culture regulation supports a mechanism but does not set requirements for every person or justify hormone treatment.
- nutrient_topic
- Choline research collection; topical membership is not evidence of a direct dietary effect. · Choline
- organism
- Human primary hepatocytes
- plain_language
- The response extended beyond an RNA measurement.
- primary_references
- [choline-p17456783] Phosphatidylethanolamine N-methyltransferase (PEMT) gene expression is induced by estrogen in human and mouse primary hepatocytes. (2007). https://pubmed.ncbi.nlm.nih.gov/17456783/ DOI: 10.1096/fj.07-8227com
- tissue_or_cell_type
- Primary hepatocytes
Choline: metabolism, signaling and nutrient connections (2026-09-17) · lines 841–852
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Primary-hepatocyte estrogen exposure · source_derived_draft · unverified_draft
### choline-estrogen-pemt-activity The increased PEMT message was accompanied by higher protein expression and enzyme activity in the hepatocyte study. Condition category: normal nutrient_topic: Choline research collection; topical membership is not evidence of a direct dietary effect. plain_language: The response extended beyond an RNA measurement. organism: Human primary hepatocytes tissue_or_cell_type: Primary hepatocytes experimental_model: Primary-hepatocyte estrogen exposure limitations: Culture regulation supports a mechanism but does not set requirements for every person or justify hormone treatment. exposure: 17-beta-estradiol treatment for 24 hours evidence_span: {"source_cache": "artifacts/choline-research/17456783.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d3585209a8c4db7cfe8b93aa2587fdd570f5e5c42bd3ea8f6195feb60b23b9da", "start_char": 0, "end_char": 1399, "text_sha256": "d3585209a8c4db7cfe8b93aa2587fdd570f5e5c42bd3ea8f6195feb60b23b9da"} [choline-p17456783] Phosphatidylethanolamine N-methyltransferase (PEMT) gene expression is induced by estrogen in human and mouse primary hepatocytes. (2007). https://pubmed.ncbi.nlm.nih.gov/17456783/ DOI: 10.1096/fj.07-8227com
Complete structured claim and evidenceEstradiol increased PEMT transcription in primary human hepatocytes in a dose-dependent manner.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/choline-research/17456783.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d3585209a8c4db7cfe8b93aa2587fdd570f5e5c42bd3ea8f6195feb60b23b9da", "start_char": 0, "end_char": 1399, "text_sha256": "d3585209a8c4db7cfe8b93aa2587fdd570f5e5c42bd3ea8f6195feb60b23b9da"}
- experimental_model
- Primary-hepatocyte estrogen exposure
- exposure
- 17-beta-estradiol treatment for 24 hours
- limitations
- Culture regulation supports a mechanism but does not set requirements for every person or justify hormone treatment.
- nutrient_topic
- Choline research collection; topical membership is not evidence of a direct dietary effect. · Choline
- organism
- Human primary hepatocytes
- plain_language
- Hormone status can affect endogenous choline-headgroup synthesis.
- primary_references
- [choline-p17456783] Phosphatidylethanolamine N-methyltransferase (PEMT) gene expression is induced by estrogen in human and mouse primary hepatocytes. (2007). https://pubmed.ncbi.nlm.nih.gov/17456783/ DOI: 10.1096/fj.07-8227com
- tissue_or_cell_type
- Primary hepatocytes
Choline: metabolism, signaling and nutrient connections (2026-09-17) · lines 828–839
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Primary-hepatocyte estrogen exposure · source_derived_draft · unverified_draft
### choline-estrogen-pemt-transcription Estradiol increased PEMT transcription in primary human hepatocytes in a dose-dependent manner. Condition category: normal nutrient_topic: Choline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Hormone status can affect endogenous choline-headgroup synthesis. organism: Human primary hepatocytes tissue_or_cell_type: Primary hepatocytes experimental_model: Primary-hepatocyte estrogen exposure limitations: Culture regulation supports a mechanism but does not set requirements for every person or justify hormone treatment. exposure: 17-beta-estradiol treatment for 24 hours evidence_span: {"source_cache": "artifacts/choline-research/17456783.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d3585209a8c4db7cfe8b93aa2587fdd570f5e5c42bd3ea8f6195feb60b23b9da", "start_char": 0, "end_char": 1399, "text_sha256": "d3585209a8c4db7cfe8b93aa2587fdd570f5e5c42bd3ea8f6195feb60b23b9da"} [choline-p17456783] Phosphatidylethanolamine N-methyltransferase (PEMT) gene expression is induced by estrogen in human and mouse primary hepatocytes. (2007). https://pubmed.ncbi.nlm.nih.gov/17456783/ DOI: 10.1096/fj.07-8227com
Complete structured claim and evidence
Where it participates (unsigned role)
DIM inhibited estradiol-induced MCF-7 proliferation in the tested estrogen-stimulated system.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/dim-research/9771935.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "2f0967e62f0757c6ff4e68f7f7f673b6ba12ec581cbc7bd5c5594bdbf1964799", "start_char": 0, "end_char": 1556, "text_sha256": "2f0967e62f0757c6ff4e68f7f7f673b6ba12ec581cbc7bd5c5594bdbf1964799"}
- experimental_model
- Ligand binding, nuclear complex, transcription and growth assays
- exposure
- DIM 10-50 micromolar in cells; rodent dosing separately
- limitations
- Preclinical evidence. Estrogen exposure, tissue and concentrations affect the response; no human cancer-treatment efficacy established.
- nutrient_topic
- Diindolylmethane (DIM) research collection; topical membership is not evidence of a direct dietary effect. · 3,3'-Diindolylmethane / DIM
- organism
- Human MCF-7 cells and rat mammary-tumor model
- plain_language
- Its effect depended on the hormonal conditions being tested.
- primary_references
- [dim-p9771935] Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. (1998). https://pubmed.ncbi.nlm.nih.gov/9771935/ DOI: 10.1093/carcin/19.9.1631
- tissue_or_cell_type
- AhR and estrogen-responsive signaling
Diindolylmethane (DIM): formation, receptor signaling, metabolism and drug interactions (2026-09-17) · lines 311–322
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Ligand binding, nuclear complex, transcription and growth assays · source_derived_draft · unverified_draft
### dim-estrogen-growth-inhibition DIM inhibited estradiol-induced MCF-7 proliferation in the tested estrogen-stimulated system. Condition category: normal nutrient_topic: Diindolylmethane (DIM) research collection; topical membership is not evidence of a direct dietary effect. plain_language: Its effect depended on the hormonal conditions being tested. organism: Human MCF-7 cells and rat mammary-tumor model tissue_or_cell_type: AhR and estrogen-responsive signaling experimental_model: Ligand binding, nuclear complex, transcription and growth assays limitations: Preclinical evidence. Estrogen exposure, tissue and concentrations affect the response; no human cancer-treatment efficacy established. exposure: DIM 10-50 micromolar in cells; rodent dosing separately evidence_span: {"source_cache": "artifacts/dim-research/9771935.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "2f0967e62f0757c6ff4e68f7f7f673b6ba12ec581cbc7bd5c5594bdbf1964799", "start_char": 0, "end_char": 1556, "text_sha256": "2f0967e62f0757c6ff4e68f7f7f673b6ba12ec581cbc7bd5c5594bdbf1964799"} [dim-p9771935] Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. (1998). https://pubmed.ncbi.nlm.nih.gov/9771935/ DOI: 10.1093/carcin/19.9.1631
Complete structured claim and evidenceResveratrol bound ERalpha and ERbeta with comparable affinity, approximately 7,000-fold weaker than estradiol in the reported assays.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Receptor binding and CHO-K1 reporter experiments.
- limitations
- No demonstrated hormone normalization in humans.
- nutrient_topic
- Resveratrol collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Resveratrol
- plain_language
- It can interact with hormone receptors, but weak affinity matters.
- primary_references
- Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. · 2000 · https://pubmed.ncbi.nlm.nih.gov/11014220/ · DOI 10.1210/endo.141.10.7721
Resveratrol: metabolites, target selectivity and cross-nutrient mechanisms (2026-09-19) · lines 398–404
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Receptor binding and CHO-K1 reporter experiments. · source_derived_draft · unverified_draft
## resveratrol-er-binding It can interact with hormone receptors, but weak affinity matters. Resveratrol bound ERalpha and ERbeta with comparable affinity, approximately 7,000-fold weaker than estradiol in the reported assays. Model: Receptor binding and CHO-K1 reporter experiments. Limitations: No demonstrated hormone normalization in humans. Evidence access: Primary abstract Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. · 2000 · https://pubmed.ncbi.nlm.nih.gov/11014220/ · DOI 10.1210/endo.141.10.7721
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.